PranaX focuses on harnessing stem-cell-derived exosomes to create next-generation regenerative biologics that can retain or restore quality of life. The company operates from the Levit Green life science campus in Houston, Texas, where it runs research, development, and manufacturing activities. Founded on the belief that exosomes can redefine approaches to aging, PranaX combines rigorous biological science with a translational platform aimed at real-world impact. Its science-driven strategy targets the growing demand for evidence-based wellness solutions that address age-related degeneration. Management emphasizes responsible innovation and scientific integrity as core tenets. The company recently secured significant growth capital to expand R&D, build infrastructure, foster strategic partnerships, and accelerate commercialization efforts.

Total raised

$17M

Funding rounds

1

Latest round

Series A

Latest activity

Jan 2026